JBI Critical Appraisal Checklist for Randomized Controlled Trials

Reviewer                                                                                             Date                                                                                     

Author                                                                                                  Year                                       Record Number                               






  1. Was true randomization used for assignment of participants to treatment groups?

2. Was allocation to treatment groups concealed?

3. Were treatment groups similar at the baseline?

4. Were participants blind to treatment assignment?

5. Were those delivering treatment blind to treatment assignment?

6. Were outcomes assessors blind to treatment assignment?

7. Were treatment groups treated identically other than the intervention of interest?

8. Was follow up complete and if not, were differences between groups in terms of their follow up adequately described and analyzed?

9. Were participants analyzed in the groups to which they were randomized?

10. Were outcomes measured in the same way for treatment groups?

11. Were outcomes measured in a reliable way?

12. Was appropriate statistical analysis used?

13. Was the trial design appropriate, and any deviations from the standard RCT design (individual randomization, parallel groups) accounted for in the conduct and analysis of the trial?

Overall appraisal:             Include   □       Exclude   □       Seek further info  □

Comments (Including reason for exclusion)